05:25 AM EDT, 08/06/2025 (MT Newswires) -- Pacira Biosciences ( PCRX ) reported Q2 non-GAAP earnings late Tuesday of $0.74 per diluted share, down from $0.89 a year earlier.

Analysts polled by FactSet expected $0.71.

Revenue for the quarter ended June 30 was $181.1 million, up from $178 million a year earlier.

Analysts surveyed by FactSet expected $183.1 million.

The company updated its revenue guidance to be between $730 million and $750 million from the prior guidance of $725 million to $765 million. Analysts polled by FactSet expect $740.8 million.